Works matching IS 10870156 AND DT 2012 AND VI 30 AND IP 7
Results: 46
Incorporating biomarkers into clinical trial designs: points to consider.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 596, doi. 10.1038/nbt.2296
- By:
- Publication type:
- Article
Therapeutic targets in cancer cell metabolism and autophagy.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 671, doi. 10.1038/nbt.2285
- By:
- Publication type:
- Article
UK's life sciences pitch.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 574, doi. 10.1038/nbt0712-574b
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 724, doi. 10.1038/nbt.2306
- Publication type:
- Article
The Multiple Myeloma Research Foundation's evolving focus on drug R&D.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 600, doi. 10.1038/nbt.2297
- By:
- Publication type:
- Article
The challenges posed by cancer heterogeneity.
- Published in:
- 2012
- By:
- Publication type:
- Interview
Around the world in a month.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 576, doi. 10.1038/nbt0712-576b
- Publication type:
- Article
Antibody specification beyond the target: claiming a later-generation therapeutic antibody by its target epitope.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 615, doi. 10.1038/nbt.2291
- By:
- Publication type:
- Article
NCATS launches drug repurposing program.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 571, doi. 10.1038/nbt0712-571a
- By:
- Publication type:
- Article
ABSOLUTE cancer genomics.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 620, doi. 10.1038/nbt.2293
- By:
- Publication type:
- Article
Canada approves stem cell product.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 571, doi. 10.1038/nbt0712-571b
- By:
- Publication type:
- Article
Combinatorial drug therapy for cancer in the post-genomic era.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 679, doi. 10.1038/nbt.2284
- By:
- Publication type:
- Article
The sweet allure of XNA.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 624, doi. 10.1038/nbt.2298
- By:
- Publication type:
- Article
Oncolytic virotherapy.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 658, doi. 10.1038/nbt.2287
- By:
- Publication type:
- Article
Compressive genomics.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 627, doi. 10.1038/nbt.2241
- By:
- Publication type:
- Article
T-cell therapy at the threshold.
- Published in:
- 2012
- By:
- Publication type:
- Interview
Keeping gut bugs from causing harm.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2312
- By:
- Publication type:
- Article
Managing knowledge-intensive workers.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 721, doi. 10.1038/nbt.2299
- By:
- Publication type:
- Article
Mending hearts in situ.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2314
- By:
- Publication type:
- Article
California's CIRM courts industry.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 572, doi. 10.1038/nbt0712-572
- By:
- Publication type:
- Article
In this issue.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. vii, doi. 10.1038/nbt.2309
- Publication type:
- Article
Beyond counting tumor cells.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 578, doi. 10.1038/nbt.2295
- By:
- Publication type:
- Article
Obama administration report underlines support for biotech.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 576, doi. 10.1038/nbt0712-576a
- By:
- Publication type:
- Article
CNVs from exome sequencing.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2311
- By:
- Publication type:
- Article
Tandem fluorescent protein timers for in vivo analysis of protein dynamics.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 708, doi. 10.1038/nbt.2281
- By:
- Publication type:
- Article
Coalition aims to accelerate translation of cell therapies.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 573, doi. 10.1038/nbt0712-573
- By:
- Publication type:
- Article
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 715, doi. 10.1038/nbt.2249
- By:
- Publication type:
- Article
From single cells to deep phenotypes in cancer.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 639, doi. 10.1038/nbt.2283
- By:
- Publication type:
- Article
TAL effector RVD specificities and efficiencies.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 593, doi. 10.1038/nbt.2304
- By:
- Publication type:
- Article
Recent patent applications in cancer biomarkers.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 619, doi. 10.1038/nbt.2308
- Publication type:
- Article
Gene therapy matures in the clinic.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 588, doi. 10.1038/nbt.2290
- By:
- Publication type:
- Article
First FDA-approved beta-amyloid diagnostic hits the market.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 575, doi. 10.1038/nbt0712-575
- By:
- Publication type:
- Article
siRNAs on the edge.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2313
- By:
- Publication type:
- Article
A hybrid approach for the automated finishing of bacterial genomes.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 701, doi. 10.1038/nbt.2288
- By:
- Publication type:
- Article
FDA approves pertuzumab.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 570, doi. 10.1038/nbt0712-570
- By:
- Publication type:
- Article
Recasting cancer trials.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 567, doi. 10.1038/nbt.2315
- Publication type:
- Article
Plant genomics roundup.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2310
- By:
- Publication type:
- Article
Reading cancer's blueprint.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 581, doi. 10.1038/nbt.2292
- By:
- Publication type:
- Article
From academic solos to industrial symphonies.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 585, doi. 10.1038/nbt.2245
- By:
- Publication type:
- Article
Jazz beefs up with EUSA biologic.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 574, doi. 10.1038/nbt0712-574a
- By:
- Publication type:
- Article
Hybrid error correction and de novo assembly of single-molecule sequencing reads.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 693, doi. 10.1038/nbt.2280
- By:
- Publication type:
- Article
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 631, doi. 10.1038/nbt.2289
- By:
- Publication type:
- Article
Swiss hope for phoenix from Merck Serono's ashes.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 569, doi. 10.1038/nbt0712-569
- By:
- Publication type:
- Article
New lysine methyltransferase drug targets in cancer.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 622, doi. 10.1038/nbt.2300
- By:
- Publication type:
- Article
Debate over details of US biosimilar pathway continues to rage.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 577, doi. 10.1038/nbt0712-577
- By:
- Publication type:
- Article
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 648, doi. 10.1038/nbt.2286
- By:
- Publication type:
- Article